These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 6179183)
1. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183 [TBL] [Abstract][Full Text] [Related]
2. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation. Fischer AM; Barrowcliffe TW; Thomas DP Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins. MacGregor IR; Dawes J; Pepper DS; Prowse CV; Stocks J Thromb Haemost; 1985 Jun; 53(3):411-4. PubMed ID: 2413564 [TBL] [Abstract][Full Text] [Related]
4. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients. Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL). Barrowcliffe TW; Gray E; Merton RE; Dawes J; Jennings CA; Hubbard AR; Thomas DP Thromb Haemost; 1986 Oct; 56(2):202-6. PubMed ID: 2433786 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the lipolytic and anticoagulative properties of heparin and pentosan polysulphate in the thoroughbred horse. Orme CE; Harris RC Acta Physiol Scand; 1997 Feb; 159(2):179-85. PubMed ID: 9055947 [TBL] [Abstract][Full Text] [Related]
7. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation. Dol F; Sié P; Dupouy D; Boneu B Thromb Haemost; 1986 Dec; 56(3):295-8. PubMed ID: 2436330 [TBL] [Abstract][Full Text] [Related]
8. The effect of a sulfated polysaccharide on antithrombin III. Czapek EE; Kwaan HC; Szczecinski M J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418 [TBL] [Abstract][Full Text] [Related]
9. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man. Ryde M; Eriksson H; Tangen O Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879 [No Abstract] [Full Text] [Related]
10. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation. Wagenvoord R; Hendrix H; Soria C; Hemker HC Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199 [TBL] [Abstract][Full Text] [Related]
11. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system--a human volunteer and experimental animal study. Marsh NA; Peyser PM; Creighton LJ; Mahmoud M; Gaffney PJ Thromb Haemost; 1985 Dec; 54(4):833-7. PubMed ID: 2418527 [TBL] [Abstract][Full Text] [Related]
12. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers. Sié P; Albarede JL; Robert M; Bouloux C; Lansen J; Chigot C; Correll S; Thouvenot JP; Boneu B Thromb Haemost; 1986 Feb; 55(1):86-9. PubMed ID: 2422778 [TBL] [Abstract][Full Text] [Related]
13. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin. Vinazzer H; Haas S; Stemberger A Thromb Res; 1980 Oct; 20(1):57-68. PubMed ID: 6163222 [No Abstract] [Full Text] [Related]
14. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54). Scully MF; Kakkar VV Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821 [TBL] [Abstract][Full Text] [Related]
15. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system. An experimental animal study. Marsh NA; Gaffney PJ Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):255-61. PubMed ID: 2427408 [TBL] [Abstract][Full Text] [Related]
16. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate. Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283 [TBL] [Abstract][Full Text] [Related]
17. Absorption of heparin, LMW heparin and SP54 after subcutaneous injection, assessed by competitive binding assay. Dawes J; Prowse CV; Pepper DS Thromb Res; 1986 Dec; 44(5):683-93. PubMed ID: 2433788 [TBL] [Abstract][Full Text] [Related]
18. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man]. Caporiccio B; Braun M; Vignaud M; Chalet M; Teste J; Codomier L; Catayée G C R Seances Soc Biol Fil; 1983; 177(4):412-20. PubMed ID: 6202380 [TBL] [Abstract][Full Text] [Related]
19. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III. Scully MF; Kakkar VV Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810 [TBL] [Abstract][Full Text] [Related]
20. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism. Scully MF; Kakkar VV Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]